Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-25-000856
Filing Date
2025-02-03
Accepted
2025-02-03 19:35:22
Documents
1
Period of Report
2025-02-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4502
  Complete submission text file 0001562180-25-000856.txt   5994
Mailing Address TWO COMMERCE SQUARE, 2001 MARKET STREET 28TH FLOOR PHILADELPHIA PA 19103
Business Address
Quigley Jill M. (Reporting) CIK: 0001799780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39926 | Film No.: 25584399

Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Issuer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)